Latest Industry Insights
Agilent Science Futures – An Interview With Rajannya Sen
In this instalment of Science Futures, Rajannya discusses the real-world applications of her research and explains how technologies have steered her work.
A Path to Net Zero
Agilent recently announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050. We spoke to them to learn how you go about making a global company with 16,300 employees a net-zero business.
Innovations and Key Themes for ASMS 2021
While many of us are still attending events remotely, ASMS 2021 has been in full swing this year with in-person talks and events. To give you a taste of the topics proving popular this year, Technology Networks has produced a round up to highlight a selection of key themes and innovations.
Using Artificial Intelligence To Detect Melanoma
To find out more about how AI can improve melanoma diagnosis, Technology Networks spoke to Dr. Kiran Motaparthi, director of dermatopathology and clinical associate professor of dermatology at the University of Florida and Julianna Ianni, PhD, vice president of AI R&D, Proscia.
Early Detection of Brain Tumors and Beyond
The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients. Dxcover has developed a new spectroscopic liquid biopsy approach that is able to identify brain tumors as small as 0.2 cm3 from a blood sample in as little as fifteen minutes.
High-Quality Chemical Detection Where It Is Needed Most
To find out more about HPIMS, Technology Networks spoke with Dr. Ching Wu, founder and chief executive officer at Excellims and a pioneer of HPIMS. In this interview, Dr. Wu talks about the advantages that the technique can offer in applications ranging from pharma PAT to clinical diagnostics, and discusses how Excellims is increasing accessibility to the technology.
Genomic Testing Service To Drive Personalized Medicine for Cancer Patients
The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.
Early Detection of Autoantibodies in Type 1 Diabetes Mellitus and Treatment Possibilities Beyond Insulin
In this article, we discuss the use of autoantibodies to diagnose and monitor type 1 diabetes mellitus and provide some future perspectives on potential therapies beyond insulin.
How Can AI Techniques Improve How We Diagnose Dementia?
Developing treatments for dementia remains one of the most forbidding challenges facing neurology. Traditionally, paper-based assessments are used by clinicians to diagnose patients. But London-based company Cognetivity says that its AI-based platform could improve diagnostics. We spoke with the company’s co-founder and chief science officer, Dr. Seyed Khaligh-Razavi, to find out more.
How LC-MS Can Support SARS-CoV-2 Research
In this interview, Kevin Wyndham, senior director of research and development at Waters, highlights how a new LC-MS method could be used to support research both during and beyond the COVID-19 pandemic.